Form D · Biotechnology
Alligator Bioscience AB (publ)
Se 223 81 Lund, V7 · CIK 0001654604
Offering snapshot reported Oct 1, 2015 · SEC filing
- Reported sold
- $10M Offering amount: $10M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 17, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 1, 2015 | Initial | $10,000,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-248606
Source: Form D, filed Oct 1, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Peter Benson | Director |
| Carl Borrebaeck | Director |
| Claes Ericsson | Director |
| Jacob Lindberg | Director |
| Kenth Petersson | Director |
| Jonas Sjogren | Director |
| Mathias Uhlen | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
C/O Medicon Village
Se 223 81 Lund, V7, 223 81
Se 223 81 Lund, V7, 223 81